141 related articles for article (PubMed ID: 35025191)
1. CENTRAL RETINAL VEIN OCCLUSION FOLLOWING BNT162B2 (PFIZER-BIONTECH) COVID-19 MESSENGER RNA VACCINE.
Shah PP; Gelnick S; Jonisch J; Verma R
Retin Cases Brief Rep; 2023 Jul; 17(4):441-444. PubMed ID: 35025191
[TBL] [Abstract][Full Text] [Related]
2. Bilateral central retinal vein occlusion following COVID-19 vaccination: Cause or coincidence?
Matri KE; Werda S; Chebbi Z; Saidane R; Doukh M; Choura R; Falfoul Y; Limaiem R; Matri LE
Eur J Ophthalmol; 2024 May; 34(3):NP78-NP81. PubMed ID: 38291623
[TBL] [Abstract][Full Text] [Related]
3. Central Retinal Vein Occlusion after COVID-19 Infection.
Nguyen NI; Eandi C; Guex-Crosier Y
Klin Monbl Augenheilkd; 2023 Apr; 240(4):509-513. PubMed ID: 37164394
[TBL] [Abstract][Full Text] [Related]
4. Branch retinal artery occlusion with unruptured retinal arterial macroaneurysm post-SARS-CoV-2 vaccination: A case report.
Murata K; Nagasato D; Tanaka H; Nakakura S; Nagasawa T; Mitamura Y; Tabuchi H
Eur J Ophthalmol; 2024 May; 34(3):NP53-NP56. PubMed ID: 37941398
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination: Case reports.
Tanaka H; Nagasato D; Nakakura S; Tanabe H; Nagasawa T; Wakuda H; Imada Y; Mitamura Y; Tabuchi H
Medicine (Baltimore); 2021 Dec; 100(50):e28236. PubMed ID: 34918688
[TBL] [Abstract][Full Text] [Related]
6. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
Pichi F; Elbarky AM; Elhamaky TR
Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022
[TBL] [Abstract][Full Text] [Related]
7. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
8. COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT.
Terashima H; Hasebe H; Okamoto F; Matsuoka N; Sato Y; Fukuchi T
Retina; 2019 Jul; 39(7):1377-1384. PubMed ID: 29689025
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema.
Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V
Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
11. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS
Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055
[TBL] [Abstract][Full Text] [Related]
13. Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial.
McAllister IL; Smithies LA; Chen FK; Mackey DA; Sanfilippo PG
JAMA Ophthalmol; 2018 Dec; 136(12):1391-1397. PubMed ID: 30347030
[TBL] [Abstract][Full Text] [Related]
14. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report.
Endo B; Bahamon S; Martínez-Pulgarín DF
Indian J Ophthalmol; 2021 Oct; 69(10):2865-2866. PubMed ID: 34571653
[TBL] [Abstract][Full Text] [Related]
15. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
[TBL] [Abstract][Full Text] [Related]
16. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
17. Central Retinal Vein Occlusion after mRNA COVID-19 Vaccination.
Ishiguro K; Hirano Y; Esaki Y; Yasukawa T
Case Rep Ophthalmol; 2023; 14(1):234-240. PubMed ID: 37383170
[TBL] [Abstract][Full Text] [Related]
18. BRANCH RETINAL VEIN OCCLUSION SECONDARY TO A RETINAL ARTERIOLAR MACROANEURYSM: A NOVEL MECHANISM SUPPORTED BY MULTIMODAL IMAGING.
Chen Y; Chen SDM; Chen FK
Retin Cases Brief Rep; 2019 Winter; 13(1):10-14. PubMed ID: 28079651
[TBL] [Abstract][Full Text] [Related]
19. Retinal vascular occlusion and SARS-CoV-2 vaccination.
Vujosevic S; Limoli C; Romano S; Vitale L; Villani E; Nucci P
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3455-3464. PubMed ID: 35612613
[TBL] [Abstract][Full Text] [Related]
20. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial.
Brown DM; Wykoff CC; Wong TP; Mariani AF; Croft DE; Schuetzle KL;
Retina; 2014 Sep; 34(9):1728-35. PubMed ID: 24914476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
